If you didn't find what you were looking for, try a new search!
A study in the April issue of SLEEP shows that brief behavioral treatment of insomnia (BBTI) produced significant improvement in the sleep parameters of older adults.
Chronic insomnia is associated with reduced ratings of emotion intensity for face expressions, according to a study in the April issue of SLEEP. Patients with insomnia rated expressions displaying sadness and fear as significantly less emotionally intense than healthy good sleepers.
The AASM has declared that Monday, March 10, 2014, is Insomnia Awareness Day. As many as 10 percent of adults have a chronic insomnia disorder, which is associated with increased risks for depression and hypertension, as well as impaired daytime alertness, mood, memory and performance.
The American Academy of Sleep Medicine (AASM) is declaring Insomnia Awareness Day on Monday, March 10, reminding those who suffer from chronic insomnia that help is available from the sleep team at a local AASM accredited sleep center. As many as 10 percent of adults have a chronic insomnia disorder, which involves ongoing difficulty falling asleep or staying asleep, or regularly waking up earlier than desired, despite an adequate opportunity for sleep. Complications of persistent insomnia include increased risks for depression and hypertension. Effective treatment options include cognitive behavioral therapy for insomnia (CBTI), which can significantly improve overall well-being and quality of life.
As part of its Effective Health Care Program, the Agency for Healthcare Research and Quality (AHRQ) is seeking public comments on the draft key questions that will provide the framework for a proposed research report, Insomnia Disorder: Diagnosis and Management Outside of Sleep Medicine Clinics.
A study published in the Sept. 1 issue of Sleep suggests that people with insomnia could not modulate activity in brain regions typically used to perform a working memory task.
A study published in the Sept. 1 issue of Sleep suggests that people with insomnia could not modulate activity in brain regions typically used to perform a working memory task.
A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.
A study in the July 15 issue of the Journal of Clinical Sleep Medicine reports that a high percentage of patients with insomnia use sleep medications off-label in the middle of the night to resume sleep.
A study in the July issue of the Journal of Clinical Sleep Medicine examined the impact of bright light therapy on insomnia in female nurses working rotating shifts. Results show that 30 minutes of bright light therapy during the first half of the evening/night shift may reduce insomnia, anxiety and depression. A commentary notes that the findings were surprisingly strong, and the treatment approach could be fairly easy to implement in the workplace.
Combat-related trauma and pre-deployment insomnia symptoms are significantly associated with higher odds of developing post-traumatic stress disorder, depression and anxiety, according to a study in the July issue of SLEEP.
A new study suggests that frequent binge drinking is associated with insomnia symptoms in older adults.
On Wednesday, May 22, the FDA Peripheral and Central Nervous System Drugs Advisory Committee discussed a new drug application for suvorexant tablets (NDA #204569), which was submitted by Merck Sharp and Dohme Corp., Worldwide Regulatory Group.
A new study provides neurobiological evidence for dysfunction in the neural circuitry underlying emotion regulation in people with insomnia, which may have implications for the risk relationship between insomnia and depression.
A new study found a relationship between sleep duration and suicidal thoughts in people with insomnia.
A study in the March 15 issue of the Journal of Clinical Sleep Medicine evaluated a consecutive series of 50 adult patients who participated in a stepped care model for chronic insomnia, in which non-responders to a less intensive therapy received a more intensive intervention.
A new study suggests that nocturia may worsen the already poor sleep of older adults with insomnia. Published in the March 15 issue of the Journal of Clinical Sleep Medicine, results show that 54 percent of all log-reported nocturnal awakenings were associated with nocturia.
A new study suggests that the bladder condition nocturia may worsen the already poor sleep of older adults with insomnia.
A new population study from Norway found that insomnia is associated with an increased risk of incident heart failure. The study followed more than 50,000 people for 11 years, noted BBC News. "We still do not know whether heart failure is really caused by insomnia, and it is still unclear why insomnia is linked to higher heart failure risk,” principal investigator Dr. Lars Laugsand told HealthDay.
A study in the February issue of the Journal of Clinical Sleep Medicine sought to to identify the optimal quantitative thresholds that differentiate older adults with insomnia from good sleepers.
Last week ABC news reported on a new study in the Journal of Clinical Sleep Medicine that examined the relationship between insomnia and suicidal thoughts. AASM member W. Vaughn McCall, MD, explained to ABC that this relationship may be mediated by dysfunctional attitudes and beliefs about sleep as well as nightmares. In a story by My Health News Daily that was featured on FOXnews.com, McCall added that the focus of his current study is to explore how this understanding may provide a new target for treatment and suicide prevention.
A new study confirms a link between insomnia and thoughts of suicide and suggests that this relationship is mediated by dysfunctional beliefs and attitudes about sleep as well as nightmares. The study suggests that the targeted assessment and treatment of specific sleep problems may reduce the risk of suicide in people with depressive symptoms.
The FDA issued a recent safety announcement and consumer update requiring drug makers to lower the recommended doses for products that contain zolpidem.
Last week, multiple news outlets including the Los Angeles Times and the New York Post reported that insomnia is costing the U.S. $63.2 billion in lost productivity. The average worker lost 11.3 days, or $2,280 because of insomnia. Most of the lost productivity due to insomnia was traced to workers who report to work, but are unproductive rather than absences. The reports were based on findings published in the Sept. issue of SLEEP.
Insomnia is costing the average U.S. worker 11.3 days, or $2,280 in lost productivity every year, according to a study in the September 1 issue of the journal SLEEP. As a nation, the total cost is 252.7 days and $63.2 billion.
Difficulty maintaining sleep is the most common insomnia symptom, according to a study in the Aug. 1 issue of SLEEP. The study involved an analysis of data from 6,791 adults who participated in the America Insomnia Survey (AIS), a cross-sectional telephone survey.
A study in the August issue of the American Journal of Public Health examined the “medicalization” of sleeplessness. Results suggest that sleeplessness complaints and insomnia diagnoses increased over time; however, they were far outpaced by prescriptions for sedative hypnotics.
Earlier this week an article in the Wall Street Journal examined efforts by pharmaceutical companies to develop new drugs for the treatment of insomnia. Rather than acting on many areas of the brain, these new drugs have specific targets such as orexin and serotonin receptors. The drug companies report that the compounds being developed will potentially have fewer side effects, be less addictive and interact less with alcohol than current medications used to treat insomnia.
Treating sleep problems with cognitive-behavioral therapy for insomnia can reduce suicidal ideation. A growing body of evidence shows that self-reported insomnia and poor sleep quality constitute modifiable risk factors for suicide. A research abstract to be presented at SLEEP 2011 found that a group cognitive-behavioral therapy for insomnia produced a statistically significant post-treatment reduction in suicidal ideation.
People with primary insomnia may be able to find relief by wearing a cap that cools the brain during sleep, suggests a research abstract that will be presented at SLEEP 2011. A reduction in metabolism in the brain's frontal cortex occurs while falling asleep and is associated with restorative sleep. Insomnia is associated with increased metabolism in the region. Researchers found that the cap reduced metabolic activity and improved sleep latency and sleep efficiency.
The AASM is offering select streaming multimedia presentations for FREE, as part of a month-long AASM Online Learning Center preview. The first online learning module available through this offer will be The Basics of Sleep Medicine – Insomnia: Etiology, Evaluation and Treatment. Developed and presented by Dr. Richard Rosenberg, PhD, AASM Director of Professional Education and Training, this presentation reviews the fundamentals of insomnia including pathophysiology, evaluation, diagnosis and treatment.
Study provides the first prospective evidence to support a directional link between common sleep complaints and incident metabolic syndrome.